| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |